This inventor holds 1 USPTO granted patent. Top assignees: Kemijska Prehrambena, Pliva Farmaceutska. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Jelka Tomasic: Innovator in Pharmaceutical Chemistry
Introduction
Jelka Tomasic is a notable inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of immunostimulating and antitumor agents. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Jelka Tomasic holds a patent for the invention titled "Tert-butyloxycarbonyl-L-tyrosyl-peptidoglycan monomer." This invention relates to a novel tert-butyloxycarbonyl-L-tyrosylpeptidoglycan monomer and its 125I-labelled Boc-Tyr-PGM derivative. The patent emphasizes the preparation and use of this compound as pharmaceuticals with immunostimulating and antitumor activity. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Throughout her career, Jelka has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Pliva Farmaceutska and Kemijska Prehrambena, where she has applied her knowledge and skills to develop groundbreaking pharmaceutical products. Her work in these organizations has further solidified her reputation as a leading inventor in her field.
Collaborations
Jelka has collaborated with several talented individuals during her career. Among her notable coworkers are Branka Vranesic and Djurdjica Ljevakovic, who have contributed to her projects and research endeavors. These collaborations have enriched her work and expanded her impact in the pharmaceutical sector.
Conclusion
Jelka Tomasic is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in immunostimulating and antitumor therapies. Her patent and collaborations highlight her commitment to innovation and excellence in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile